Skip to main content
HeartCited

NMN (Nicotinamide Mononucleotide) için Arterial Stiffness

C

Single RCT showed improved pulse wave velocity in middle-aged adults. NAD+ restoration mechanism is compelling. Larger cardiovascular-specific trials are ongoing.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dnmn\u0026condition\u003Darterial\u002Dstiffness'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            C

        

        

            
Sonuç

            
            
Single RCT showed improved pulse wave velocity in middle-aged adults. NAD+ restoration mechanism is compelling. Larger cardiovascular-specific trials are ongoing.

            
            
        

    











    
    

        
        

            

  
Key Statistics





            


    

        
2

        
Çalışmalar

    

    

        
100

        
Katılımcılar

    

    

        
            
            ↑
            
        
        
Positive

    

    

        C

        
Derece

    




        


        
        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
Yaygın Kullanılan Dozajlar

                

                    
                    

                        
general:

                        
250-500 mg/day

                    

                    
                    

                        
antiagingprotocols:

                        
500-1,000 mg/day

                    

                    
                

                
                

                    Üst sınır: Not formally established; up to 1,200 mg/day used in human trials without significant adverse e
                

                
            

            

            

            
            

                En iyi alım zamanı: Morning on empty stomach or with light meal; sublingual for enhanced bioavailability
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
Bildirilen Yan Etkiler

                    
    
                        
                        
  • 
                            ⚠
                            Generally well-tolerated
                        
    • 
                        
                        
  • 
                            ⚠
                            Mild gastrointestinal discomfort
                        
    • 
                        
                        
  • 
                            ⚠
                            Flushing (rare)
                        
    • 
                        
                        
  • 
                            ⚠
                            Headache (rare)
                        
    • 
                        
                    

                

                

                
                

                    
Bilinen Etkileşimler

                    
    
                        
                        
  • 
                            ●
                            May interact with NAD+-dependent medications
                        
    • 
                        
                        
  • 
                            ●
                            Theoretical interaction with diabetes medications (may affect glucose metabolism)
                        
    • 
                        
                    

                

                

                
                

                    

                        Tolere edilebilir üst alım: Not formally established; up to 1,200 mg/day used in human trials without significant adverse e
                    

                

                
            

            

                Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does NMN (Nicotinamide Mononucleotide) help with Arterial Stiffness?
            
        
        

            Based on 2 studies with 100 participants, there is limited but promising evidence that NMN (Nicotinamide Mononucleotide) may support Arterial Stiffness management. Our evidence grade is C (Some Evidence).
        

    

    
    

        
            How much NMN (Nicotinamide Mononucleotide) should I take for Arterial Stiffness?
            
        
        

            Studies have used various dosages. A commonly studied range is 250-500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of NMN (Nicotinamide Mononucleotide)?
            
        
        

            Reported side effects may include Generally well-tolerated, Mild gastrointestinal discomfort, Flushing (rare), Headache (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for NMN (Nicotinamide Mononucleotide) and Arterial Stiffness?
            
        
        

            We rate the evidence as Grade C (Some Evidence). This rating is based on 2 peer-reviewed studies with 100 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                

                    
Şu durum için diğer içerikler: Arterial Stiffness

                    

                        
                        
                            Vitamin K2
                            B

                        
                        
                    

                

                

                
                

                    
NMN (Nicotinamide Mononucleotide) diğer sağlık durumları için

                    

                        
                        
                            Heart Failure
                            D

                        
                        
                    

                

                
            

        

        

    


    
    












    

        FDA Sorumluluk Reddi:
        Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.